Oravax's vaccine technology is highly scalable for manufacturing and is easily transferable for wide scale logistical distribution, as there is no need for freezer storage
For the six months ended September 30, 2021, Lyka had reported revenues of Rs 109.87 crore
GlaxoSmithKline Pharmaceuticals Limited has reported consolidated financial results for the period ended September 30, 2021
The Research Services and Biosimilars business segments reported a growth of 17% and 10%, respectively
The revised deal involves a cash consideration only as against the earlier proposal of cash and equity
Transformational partnership establishes PCI as a CDMO and broadens capabilities across drug product lifecycle
Since its inception, the company has either acquired or taken a majority stake in five companies
The aim is to first produce Covid-19 vaccines and then add more vaccines in the years to come
Its store network grew from 144 stores in March 2019 to 236 stores. It has a presence in 23 cities across Maharashtra, Goa and Karnataka, employing more than 4,600 people.
The issue will consist of the issuance of fresh equity shares worth up to Rs 331.60 crore and an offer for sale (OFS) of Rs 500 crore by promoters and existing shareholders
Subscribe To Our Newsletter & Stay Updated
